Our mission

OncoSil Medical is a global medical device company focused on Interventional Oncology. Our mission is to improve the outcomes for people living with cancer by utilising the selected and targeted intratumoural placement of Phosphorous-32 (³²P) Microparticles in combination with chemotherapy.

OncoSil™ is our brachytherapy device.  Its targeted approach enables healthcare professionals to deliver a greater radiation dose directly into the tumour compared to external beam radiotherapy, while sparing surrounding critical organs¹.

We believe in our technology and its ability to have a truly positive impact in Oncology.

Reference: 1. Skowronek J. J Contemp Brachytherapy 2017; 9: 581-589.